Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Surgical Devices
evalveinc.com

See what CB Insights has to offer

Founded Year

1999

Stage

Acquired | Acquired

Total Raised

$117.4M

Valuation

$0000 

About Evalve

Evalve is a medical device company seeking to revolutionize the treatment of mitral valve disease with a minimally invasive approach.On September 11th, 2009, Evalve was acquired by Abbott at a valuation of $320M.

Evalve Headquarter Location

4045 Campbell Avenue

Menlo Park, California, 94025,

United States

650-330-8100

Latest Evalve News

Avive Solutions raises $7 million

Jun 26, 2020

Avive Solutions, the company focused on addressing the global public health issue of Sudden Cardiac Arrest, has raised $7 million in funding, bringing the total raised to over $15 Million since the Company’s inception in 2017. This round was led by new investor, Laerdal Million Lives Fund, with participation from Kenko Venture Partners, Irish Angels, and numerous renowned medical device executives and healthcare leaders from current and past companies such as ResMed, Hill-Rom, Evalve, and Northwestern Health. With national average survival rates of <10%, SCA accounts for over 350,000 out of hospital deaths per year in the US, and it is the leading cause of death of people over age 40, and the leading cause of death for student-athletes. While CPR can help to “buy time,” a person in SCA must ultimately receive a high energy defibrillation shock delivered from an AED to survive, and every minute that a person goes without receiving a defibrillation shock reduces their chances of survival. The California-based startup is developing a “next-generation” automated external defibrillator and software solutions for out of hospital cardiac arrest response in an effort to increase survival rates. “Over the past two decades, despite the AED industry deploying millions of units throughout the U.S., there has been no meaningful increase in SCA survival rates across the country. For more than 20 years, the industry’s status quo approach to addressing this significant problem has been to deploy more and more hardware that has modest incremental feature improvements, without addressing the true problem that is inhibiting tens of thousands of additional lives from being saved every year – which is simply getting AEDs where they are needed, when they are needed.” – Sameer Jafri, cofounder and president of Avive Solutions. “By bringing data-driven connectivity in the form of an integrated software and device platform, we believe Avive can play a meaningful role across the Chain of Survival for cardiac arrest. By building a superior AED which includes features that create accessible CPR training, and developing a new system to improve rapid defibrillation, while also creating a data link to professional first responders, we are excited about the life-saving technology and opportunity Avive has in front of them, and we are passionate about helping them bring their product to millions of SCA patients.” – Jeff Trost, Managing Partner of Laerdal Million Lives Fund. Share this A really good email covering top news. Leave this field empty if you're human:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Evalve Patents

Evalve has filed 121 patents.

The 3 most popular patent topics include:

  • Cardiac anatomy
  • Cardiac surgery
  • Valvular heart disease
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/23/2019

11/9/2021

Cardiac anatomy, Valvular heart disease, Cardiac surgery, Cardiology, Congenital heart defects

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/23/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/9/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Cardiac anatomy, Valvular heart disease, Cardiac surgery, Cardiology, Congenital heart defects

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.